"
Reserpine-Induced Progressive Parkinsonism in Mice Predisposed and Non-Predisposed to Depressive-Like Behavior"
written by Manuela B. L. Soares, Leonardo B. Lopes-Silva, Marcela Becegato, Vinicius S. Bioni, Alvaro C. Lima, Gabriela M. Ferreira, Ywlliane Meurer, Regina H. Silva,
published by
Journal of Behavioral and Brain Science,
Vol.11 No.11, 2021
has been cited by the following article(s):
|
[1]
|
Predictive validation of the repeated low-dose reserpine rodent model of parkinsonism
Experimental Brain Research,
2026
DOI:10.1007/s00221-026-07316-8
|
|
|
|
|
[2]
|
Ameliorative effects on motor and biochemical deficits of celosia cristata and callistemon citrinus methanolic leaf extracts in a reserpine-induced mouse model of parkinsonism: behavioral, antioxidant and MAO-B evidence
Neurophysiology,
2026
DOI:10.1007/s11062-026-10027-z
|
|
|
|
|
[3]
|
Preventive beneficial effects of cannabidiol in a reserpine-induced progressive model of parkinsonism
Frontiers in Pharmacology,
2025
DOI:10.3389/fphar.2025.1539783
|
|
|
|
|
[4]
|
Animal Approaches to Studying Risk Factors for Parkinson’s Disease: A Narrative Review
Brain Sciences,
2024
DOI:10.3390/brainsci14020156
|
|
|
|
|
[5]
|
Neuroprotective potential of Afzelin: A novel approach for alleviating catalepsy and modulating Bcl-2 expression in Parkinson's disease therapy
Saudi Pharmaceutical Journal,
2024
DOI:10.1016/j.jsps.2023.101928
|
|
|
|
|
[6]
|
Sleep deprivation induces late deleterious effects in a pharmacological model of Parkinsonism
Experimental Brain Research,
2024
DOI:10.1007/s00221-024-06811-0
|
|
|
|